Membranoproliferative Glomerulonephritis Type I: A Correlation Between Treated (138) and Untreated (108) Patients

  • F. Ferrario
Chapter
Part of the Developments in Nephrology book series (DINE, volume 30)

Abstract

Idiopathic membranoproliferative glomerulonephritis (MPGN) is a well defined histologic entity of unknown pathogenesis that leads to renal failure in the majority of patients, with renal survival of 50% after ten years from RB..

Keywords

Corticosteroid Glomerulonephritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McEnery, P. T., McAdams, A. J. and West, C. D. Medicine 5: 401–424, 1986.Google Scholar
  2. 2.
    A report of the international study of kidney disease in children. Alternate day steroid therapy in membrano-proliferative glomerulonephritis: a randomized controlled trial. Kidney Int. 21: 12, 1982 (A).Google Scholar
  3. 3.
    Tiller, D. J., Clarkson, A. R., Mathew, T., Thompson, N., Row, G., Lauer, C., Hobbs, J. and Seymour, A. Proc. 8th Congr. Nephrol. Athens 345–351, 1981.Google Scholar
  4. 4.
    Cattran, D. C., Cardella, C. J., Roscol, J. M., Charron, R. C., Rance, P. C., Ritchie, S. M. and Corey, P. N. Kidney Int. 27: 436–441, 1985PubMedCrossRefGoogle Scholar
  5. 5.
    Zimmermann, S. W., Moorthy, A. V., Dreer, A. V., Friedman, A. and Varanasi, V. Am. J. Med. 75: 920–927, 1983CrossRefGoogle Scholar
  6. 6.
    Donadio, J. V., Anderson, C. F., Mitchell III, J.C., Holley, K.E., Ilstruf, D.D.M., Fuster, V. and Chesebro, J.H. N. Engl. J. Med. 310: 142–146, 1984CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1991

Authors and Affiliations

  • F. Ferrario
    • 1
  1. 1.Division of NephrologySan Carlo HospitalMilanoItaly

Personalised recommendations